Mental health startup Kintsugi is shutting down and open sourcing its AI tech for detecting depression and anxiety from speech, after not securing FDA clearance
Mental health startup Kintsugi is shutting down and open-sourcing its AI tech to detect depression and anxiety, after failing to secure FDA clearance
Instead, a mental health startup shut down and open-sourced its tech. … For the past seven years, the California-based startup Kintsugi …
Paradromics says it received FDA approval for a human trial of its Connexus brain implant, aimed at restoring speech to those with severe motor impairments
The Austin-based startup will test its high-bandwidth device to help restore speech in people with extremely limited movement.
How AI-powered tools like PainChek, an app that scans a person's face for tiny muscle movements, are helping health care providers better assess patients' pain
For years at Orchard Care Homes, a 23‑facility dementia-care chain in northern England, Cheryl Baird watched nurses fill … X: @deenamousa , @deenamousa , @deenamousa , @deenamousa , and @deenamousa Bl...
Apple Watch's hypertension notifications and sleep score will come to some older models with watchOS 26; Apple expects FDA clearance for the notifications soon
New hypertension notifications are coming to the Watch Series 9 and up. … Apple just announced a bunch of new health-tracking …
Oxford-based Ultromics, which has developed the first FDA-cleared, Medicare-reimbursed AI tools for cardiology diagnostics, raised a $55M Series C
The funding will accelerate Ultromics' mission to advance heart disease detection and scale EchoGo®, its AI platform for earlier, more accurate diagnoses.
Elon Musk departs the Trump administration as a “special government employee”, defending DOGE's mission to reduce wasteful government spending
Now the job falls to the insidious fossil-fuel-funded creep Russell Vought, their henchman at OMB. E.W. Niedermeyer / @niedermeyer.online : “Say what you will about Elon Musk, the man thinks ahead.” ...
The US FDA plans to deploy AI tools to all centers by June 30, 2025 to speed up scientific reviews, after completing a pilot and naming its first AI chief
FDA Artificial Intelligence AI and Machine Learning Biotech — The FDA has appointed its first chief artificial intelligence officer …
Sources: OpenAI employees met with the US FDA and two DOGE associates multiple times in recent weeks to discuss cderGPT, a project likely around drug evaluation
High-ranking OpenAI employees have met with the FDA multiple times in recent weeks to discuss AI and a project called cderGPT.
Google rolls out Loss of Pulse Detection to the Pixel Watch 3 in the US after getting FDA clearance in February 2025; the feature rolled out in Europe in 2024
Following the April 2025 OTA update and Scam Detection yesterday, Google is now rolling out Loss of Pulse Detection in the US.